Zobrazeno 1 - 10 of 63 pro vyhledávání: '"Luciano, Wannesson"'
1
Akademický článek
Prognostic implication of PD-L1 in early-stage non-small cell lung cancer: a retrospective single-centre study
Autor: Elona Cekani, Carolina Martorelli, Francesco Martucci, Miriam Patella, Stefano Cafarotti, Antonio Valenti, Stefania Freguia, Francesca Molinari, Patrizia Froesch, Milo Frattini, Anastasios Stathis, Luciano Wannesson
Publikováno v: Swiss Medical Weekly, Vol 153, Iss 9 (2023)
BACKGROUND: The prognostic role of programmed death-ligand 1 (PD-L1) expression in patients with localised and locally advanced non-small cell lung cancer has not been fully elucidated. This information could help to better interpret recent and upcom
Externí odkaz: https://doaj.org/article/a20c342a3bef452da551c9d053dbd235
Zobrazit plný text záznamu
2
Akademický článek
Lurbinectedin improves macular edema in a case of central retinal vein occlusion
Autor: Filippo Simona, Feliciana Menna, Luciano Wannesson, Alessandro Meduri, Gabriella De Salvo, Giuseppe Querques
Publikováno v: American Journal of Ophthalmology Case Reports, Vol 28, Iss , Pp 101743- (2022)
Purpose: To evaluate the response to lurbinectedin in a case of macular edema, secondary to central retinal vein occlusion (CRVO). Serial spectral domain optical coherence tomography (SD-OCT) scans were taken in a 70-year-old man with a 24-month hist
Externí odkaz: https://doaj.org/article/26ae7843aef743ada8ab9234b0ca2474
Zobrazit plný text záznamu
3
Akademický článek
Real-world experience with capmatinib in exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program
Autor: Oliver Illini, Hannah Fabikan, Aurélie Swalduz, Anders Vikström, Dagmar Krenbek, Michael Schumacher, Elizabeth Dudnik, Michael Studnicka, Ronny Öhman, Robert Wurm, Luciano Wannesson, Nir Peled, Waleed Kian, Jair Bar, Sameh Daher, Alfredo Addeo, Ofer Rotem, Georg Pall, Alona Zer, Akram Saad, Tanja Cufer, Hadas Gantz Sorotsky, Sayed M. S. Hashemi, Katja Mohorcic, Ronen Stoff, Yulia Rovitsky, Shoshana Keren-Rosenberg, Thomas Winder, Christoph Weinlinger, Arschang Valipour, Maximilian J. Hochmair
Publikováno v: Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Patients with non-small cell lung cancer (NSCLC) presenting with mesenchymal–epithelial transition ( MET ) exon 14 skipping mutation have an unfavorable prognosis with standard treatments. Capmatinib is a selective MET inhibitor, which
Externí odkaz: https://doaj.org/article/0bbcd42c11e74cbfb91361945db11f28
Zobrazit plný text záznamu
4
Akademický článek
Risk factors for renal toxicity after inpatient cisplatin administration
Autor: Elena Galfetti, Alessandra Cerutti, Michele Ghielmini, Emanuele Zucca, Luciano Wannesson
Publikováno v: BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background After several decades, cisplatin continues to be an essential drug for the treatment of several tumors, however, its potential nephrotoxicity is still a clinically relevant issue. Identification of predisposing factors for renal t
Externí odkaz: https://doaj.org/article/5bac10a54abe4a03974ca88ca0090164
Zobrazit plný text záznamu
9
Akademický článek
Correction to: Functional and clinical significance of ROR1 in lung adenocarcinoma
Autor: Giovanna Schiavone, Samantha Epistolio, Vittoria Martin, Francesca Molinari, Jessica Barizzi, Luca Mazzucchelli, Milo Frattini, Luciano Wannesson
Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz: https://doaj.org/article/e4ec46c64bac4e11a0b940be037ddffd
Zobrazit plný text záznamu
10
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Autor: Mahmoud Elsawy, Julio C. Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D. Rudzki, Saurabh Dahiya, Kathleen Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martin Garcia-Sancho, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thieblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei-Jhih Wang, Caitlyn T. Solem, Julia Thornton Snider, Paul Cheng, Christina To, Marie José Kersten
Publikováno v: Blood, 140(21), 2248-2260. American Society of Hematology
Elsawy, M, Chavez, J C, Avivi, I, Larouche, J-F, Wannesson, L, Cwynarski, K, Osman, K, Davison, K, Rudzki, J D, Dahiya, S, Dorritie, K A, Jaglowski, S M, Radford, J, Morschhauser, F, Cunningham, D, Martin Garcia-Sancho, A, Tzachanis, D, Ulrickson, M L, Karmali, R, Kekre, N, Thieblemont, C, Enblad, G, Dreger, P, Malladi, R, Joshi, N, Wang, W-J, Solem, C T, Snider, J T, Cheng, P, To, C & Kersten, M J 2022, ' Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma ', Blood . https://doi.org/10.1182/blood.2022015478
Here, we report the first comparative analysis of patient-reported outcomes (PROs) with chimeric antigen receptor T-cell therapy vs standard-of-care (SOC) therapy in second-line relapsed/refractory large B-cell lymphoma (R/R LBCL) from the pivotal ra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::461f94cf5a147a9b936b0e8596bcfa87
https://pure.amc.nl/en/publications/patientreported-outcomes-in-zuma7-a-phase-3-study-of-axicabtagene-ciloleucel-in-secondline-large-bcell-lymphoma(97d2d6dc-1bf2-4675-9ee8-a90efa10aa7d).html
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje